Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab in the Framework Of Use in Special Situations Prior to Commercialisation in Spain
NCT06487065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33
Last updated 2025-10-02
Summary
The aim of this study is to provide the first results on the use of tezepelumab under clinical practice conditions in severe asthma patients who participated in the "foreign medication supply" program in Spain.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-17
- Primary Completion
- 2024-10-25
- Completion
- 2024-10-25
Countries
- Spain
Study Locations
More Related Trials
-
A Study for Observing Severe Asthma in Patients Treated With Tezepelumab
NCT05677139 ·Status: COMPLETED
-
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
NCT06023589 ·Status: RECRUITING ·Phase: PHASE3
-
Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
NCT03706079 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States
NCT05329194 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma
NCT03347279 ·Status: COMPLETED ·Phase: PHASE3
-
REVErsing Airway Remodelling With Tezepelumab
NCT05651841 ·Status: RECRUITING ·Phase: PHASE3
-
Tezspire Cardiac Events PASS
NCT06951867 ·Status: RECRUITING
-
Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma
NCT03406078 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Retrospective Study on Clinical Outcomes of Patients Receiving Benralizumab in Spain.
NCT04648839 ·Status: COMPLETED
-
The Inflammatory Profile of Exacerbations in Patients With Severe Asthma Receiving Tezepelumab: The TezEx Study
NCT06666504 ·Status: NOT_YET_RECRUITING
-
Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma
NCT03927157 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain
NCT04126499 ·Status: COMPLETED
-
Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea
NCT06998095 ·Status: NOT_YET_RECRUITING
-
Tezepelumab on Airway Structure and Function in Patients With Uncontrolled Moderate-to-severe Asthma
NCT05280418 ·Status: COMPLETED ·Phase: PHASE3
-
TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)
NCT05729711 ·Status: ACTIVE_NOT_RECRUITING
-
Reslizumab in Patients With Severe Asthma Who Failed to Respond to Omalizumab
NCT03074942 ·Status: COMPLETED ·Phase: PHASE2
-
Tezepelumab Treatment in Korean Severe Asthma Patients
NCT06438913 ·Status: NOT_YET_RECRUITING
-
Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma
NCT04673630 ·Status: COMPLETED ·Phase: PHASE1
-
Tezepelumab PRO Study
NCT05922891 ·Status: COMPLETED
-
Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)
NCT03688074 ·Status: COMPLETED ·Phase: PHASE2
-
Double-blind, Multiple Dose Study of Tezepelumab (AMG 157) in Adults With Mild Atopic Asthma
NCT01405963 ·Status: COMPLETED ·Phase: PHASE1
-
Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe Asthma
NCT07302516 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Asthma Research in Children and Adolescents
NCT04480242 ·Status: ACTIVE_NOT_RECRUITING
-
Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab
NCT05139381 ·Status: ACTIVE_NOT_RECRUITING
-
Tezepelumab Home Use Study
NCT03968978 ·Status: COMPLETED ·Phase: PHASE3